Anticuerpos monoclonales en enfermedades alérgicas: Desarrollo, farmacología y aplicaciones clínicas
Selene Pury, Ricardo José Saranz, María José Irastorza, Laura Veronica Sasia, Pilar Visconti, Graciela Alegre, Natalia Andrea Lozano, Yanina Viviana Berardi, Alejandro Lozano · 2024
Read Anticuerpos monoclonales en enfermedades alérgicas: Desarrollo, farmacología y aplicaciones clínicas by Selene Pury, Ricardo José Saranz, María José Irastorza, Laura Veronica Sasia, Pilar Visconti, Graciela Alegre, Natalia Andrea Lozano, Yanina Viviana Berardi, Alejandro Lozano (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11905782.txt.
Description
Selene Pury and eight colleagues review monoclonal antibodies for allergic ills, in a Spanish-language article from twenty twenty-four. Better grasp of immunity and of antibody craft has produced targeted therapies. They block cytokines or the receptors that drive these processes. Treated ills include asthma, allergic rhinitis, hives, and severe eczema.
The article traces how the drugs grew since the first approved mouse antibody in nineteen eighty-six. Chimeric, humanized, and fully human versions followed in progress. Making them more human cut immune reactions against the drugs and made them safer. The authors set out how the drugs were made and how they act, in detail. How the body handles the drugs gets full treatment too. The main focus is use in care across these ills. It serves doctors who weigh the drugs for patients with severe allergy.
Catalog record
| CREATOR | Selene Pury, Ricardo José Saranz, María José Irastorza, Laura Veronica Sasia, Pilar Visconti, Graciela Alegre, Natalia Andrea Lozano, Yanina Viviana Berardi, Alejandro Lozano |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |